Thanks to Dr. Bradby for today’s Morning Report!
Stroke in Sickle Cell Disease
Neurological and Hematological Emergency
- 24% of sickle cell disease patients have a stroke by the age of 45 years
- these people have an increased risk of secondary stroke 2-3 years after initial CVA (recurrence rate of 66%)
- Ischemic variant – 54% of all CVAs is highest during the first decade of life and after age 30
- In the 20s – hemorrhagic CVA is most predominant
- 10-30% of SCD patients have “silent strokes”
- Radiologic findings consistent with diffuse white matter disease
- Associated with cognitive deficiencies
Prevention:
- Hydroxyurea
- Chronic transfusion with goal of maintain HbS <30% (STOP 1, 2 trials – Optimizing Primary Stroke Prevention in Sickle Cell Anemia)
Management:
- Head CT, Stroke Labs, Consults
- Treatment: EXCHANGE Transfusion; no place for tPA in these patients
- Consults: Neurology, Hematology, MICU, Renal (for Shiley placement)
- Call blood back – need 8-10 units for exchange transfusion
- Call NY Blood Blank and ask to initiate exchange transfusion – this can take several hours
- Place Central Line – need a large bore femoral line for exchange (ex. Shiley)
- This is where your renal consult comes in if necessary
References:
- Luis A. Verduzco and David G Nathan. Sickle Cell Disease and Stroke. Blood. December 10, 2009. Vol. 114, no 25, p5117-5125.
- Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006 Jun;5(6):501-12. Review. PubMed PMID: 16713922.
Jay Khadpe MD
- Editor in Chief of "The Original Kings of County"
- Assistant Professor of Emergency Medicine
- Assistant Residency Director
- SUNY Downstate / Kings County Hospital
Latest posts by Jay Khadpe MD (see all)
- Save of the Month! December 2015 - December 23, 2015
- Morning Report: Unprovoked First Seizure in Adults - September 11, 2015
- Morning Report: Extramural Deliveries in the Emergency Room - September 10, 2015
0 Comments